Literature DB >> 2958623

Renal mechanisms of human alpha-atrial natriuretic peptide in man.

J Brown1, L Corr.   

Abstract

1. Eight normal volunteers were studied on two separate days after being dehydrated overnight. Each volunteer received a background intravenous infusion of arginine vasopressin (5.5 X 10(-7) i.u. kg-1 min-1) on both days and also received an intravenous infusion of human alpha-atrial natriuretic peptide (15 pmol kg-1 min-1) plus carrier on one day and carrier alone on the other. The ensuing changes in blood pressure, in the excretion of urinary solutes, and in the excretion of solute-free water were recorded. 2. The infusion of atrial peptide had a small hypotensive effect, and increased the rate of excretion of sodium but not of potassium. There were no significant changes of urinary osmolality or of creatinine clearance. 3. The infusion of atrial peptide increased the rate of solute-free water reabsorption and did so in direct proportion to its effect of increasing sodium excretion. 4. A further six normal, dehydrated volunteers were studied on each of two days after taking 500 mg of lithium carbonate on the previous evening. On one day, they received an intravenous infusion of human alpha-atrial natriuretic peptide (15 pmol kg-1 min-1) plus carrier and on the other day they received carrier alone. The excretion of urinary electrolytes and the creatinine clearance were recorded. 5. The infusion of atrial peptide produced significant increases in the rates of excretion of both sodium and lithium, but there were no such changes of creatinine clearance. 6. Another six normal volunteers were studied on each of two days. On each day they drank 2 l of water over 30 min and then water to replace their urinary losses. They also received loading doses and maintenance infusions of inulin and sodium para-aminohippurate. Once a full water diuresis had become established, each subject received an infusion of human alpha-atrial natriuretic peptide (15 pmol kg-1 min-1) plus carrier on one day and carrier alone on the other, exactly as before. The excretion of sodium and solute-free water, and the clearances of inulin and para-amino-hippurate were recorded. 7. The infusion of atrial peptide increased the rates of excretion of both sodium and solute-free water. It also increased the clearance of inulin, but not that of para-aminohippurate. 8. These results suggest that, in our volunteers, infusion of human alpha-atrial natriuretic peptide increases sodium excretion mainly by increasing the delivery of sodium along the renal tubule from sites upstream of the loop of Henle.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2958623      PMCID: PMC1192491          DOI: 10.1113/jphysiol.1987.sp016560

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  28 in total

1.  The effect of variations in solute excretion and vasopressin dosage on the excretion of water in the dog.

Authors:  J ORLOFF; H N WAGNER; D G DAVIDSON
Journal:  J Clin Invest       Date:  1958-03       Impact factor: 14.808

2.  Renal effects of human alpha-atrial natriuretic polypeptide.

Authors:  T Kuribayashi; M Nakazato; M Tanaka; M Nagamine; T Kurihara; K Kangawa; H Matsuo
Journal:  N Engl J Med       Date:  1985-05-30       Impact factor: 91.245

Review 3.  Lithium clearance: a new method for determining proximal and distal tubular reabsorption of sodium and water.

Authors:  K Thomsen
Journal:  Nephron       Date:  1984       Impact factor: 2.847

4.  Micropuncture studies of the renal effects of atrial natriuretic substance.

Authors:  J P Briggs; B Steipe; G Schubert; J Schnermann
Journal:  Pflugers Arch       Date:  1982-12       Impact factor: 3.657

5.  Inhibition of vasopressin action by atrial natriuretic factor.

Authors:  M A Dillingham; R J Anderson
Journal:  Science       Date:  1986-03-28       Impact factor: 47.728

6.  A micropuncture study of the renal handling of lithium.

Authors:  J P Hayslett; M Kashgarian
Journal:  Pflugers Arch       Date:  1979-06-12       Impact factor: 3.657

7.  Atrial natriuretic factor in human blood.

Authors:  T Yamaji; M Ishibashi; F Takaku
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

8.  Lack of a direct effect of atrial natriuretic factor in the rabbit proximal tubule.

Authors:  M Baum; R D Toto
Journal:  Am J Physiol       Date:  1986-01

9.  Atrial natriuretic factor--a circulating hormone stimulated by volume loading.

Authors:  R E Lang; H Thölken; D Ganten; F C Luft; H Ruskoaho; T Unger
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

10.  Comparison of three measures of proximal tubular reabsorption: lithium clearance, occlusion time, and micropuncture.

Authors:  K Thomsen; N H Holstein-Rathlou; P P Leyssac
Journal:  Am J Physiol       Date:  1981-10
View more
  4 in total

1.  Effects of interrupting the renin-angiotensin system on sodium excretion in man.

Authors:  J Brown
Journal:  J Physiol       Date:  1988-01       Impact factor: 5.182

2.  DOPA decarboxylase inhibition does not influence the diuretic and natriuretic response to exogenous alpha-atrial natriuretic peptide in man.

Authors:  S Kageyama; J Brown; R Causon; M O'Flynn; V Aber
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Vascular responses to local atrial natriuretic peptide infusion in man.

Authors:  D J Webb; N Benjamin; M J Allen; J Brown; M O'Flynn; J R Cockcroft
Journal:  Br J Clin Pharmacol       Date:  1988-09       Impact factor: 4.335

4.  Frusemide pretreatment blunts the inhibition of renal tubular sodium reabsorption by ANF in man.

Authors:  J McMurray; A D Struthers
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.